The Preuss Foundation Interleukin-2/LAK Cell Treatment of Brain Tumors Seminar I

June 10, 1987
Dallas, Texas

Gale A. Granger, Ph.D.
University of California, Irvine
Irvine, California

Elizabeth A. Grimm, Ph.D.
University of Texas System Cancer Center
Houston, Texas

Marylou Ingram, M.D.
Huntington Medical Research Institute
Pasadena, California

Steven Jacobs, M.D., Ph.D.
Albert Einstein College of Medicine
Bronx, New York

Mr. Brent Jorgeson
Healthcare International
Austin, Texas

Paul L. Kornblith, M.D.
Albert Einstein College of Medicine
Bronx, New York

Carol A. Kruse, Ph.D.
University of Colorado
Denver, Colorado

Maria Kuppner, Ph.D.
University Hospital, Chuv
Lausanne, Switzerland

Kevin O. Lillehei, M.D.
University of Colorado Health Science Center
Denver, Colorado

M. Stephen Mahaley, Jr., M.D., Ph.D. - Chairperson
University of Alabama
Birmingham, Alabama
 

Randall E. Merchent, Ph.D.
Virginia Commonwealth University
Richmond, Virginia

Richard P. Moser, M.D.
M.D. Anderson Hospital and Tumor Institute
Houston, Texas

Robert G. Peterson, M.D.
Children’s Hospital
Boston, Massachusetts

Mark Rosenblum, M.D.
University of California, San Francisco
San Francisco, California

Harold F. Young, M.D.
Virginia Commonwealth University
Richmond, Virginia

CONTACT

© 2019 The Preuss Foundation, Inc.

2223 Avenida de la Playa, Ste. 220

La Jolla, CA 92037

Tel 858-454-0200